Production-Ready AI: Evidence, Multimodal Agents, and Observability Take Hold
Published Jan 4, 2026
Worried your AI pilots won’t scale? In the last two weeks (late Dec 2025–early Jan 2026) vendors moved from demos to production: OpenAI rolled Evidence out to more enterprise partners for structured literature review and “grounded generation” (late Dec), DeepMind published video+text multimodal advances, and an open consortium released office-style multimodal benchmarks. At the infrastructure level OpenTelemetry PRs and vendors like Datadog added LLM traces so prompt→model→tool calls show up in one trace, while IDP vendors (Humanitec) and Backstage plugins treat LLM endpoints, vector stores and cost controls as first‐class resources. In healthcare and biotech, clinical LLM pilots report double‐digit cuts in documentation time with no significant rise in major safety events, and AI‐designed molecules are entering preclinical toxicity validation. The clear implication: prioritize observability, platformize AI services, and insist on evidence and safety.